4.76 USD
↘ 0.08 (1.65%)AT CLOSE (03:59 PM EDT)
LeonaBio, Inc. Common Stock
LONANASDAQ • USD
4.80
↗ 0.04 (0.74%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
4.80
↗ 0.04 (0.74%)
Market: CLOSED
LeonaBio, Inc. Common Stock (LONA) trades at $4.85 per share. Technical indicators currently signal "Strong Sell". Notable factors include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Oct 26, 2026.
Open?$4.80
High?$5.00
Low?$4.55
Prev. Close?$4.84
Volume?38.9K
Avg. Volume?350.9K
VWAP?$4.86
Rel. Volume?0.11x
Bid / Ask
Bid?$4.10 × 800
Ask?$4.88 × 100
Spread?$0.78
Midpoint?$4.49
Valuation & Ratios
Market Cap?44.8M
Shares Out?9.4M
Float?4.9M
Float %?52.1%
P/E Ratio?N/A
P/B Ratio?1.33
EPS?-$15.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
Employees
19
Market Cap
45.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2020-09-18
Address
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL, WA 98011
Phone: (425) 620-8501
BOTHELL, WA 98011
Phone: (425) 620-8501
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?1.79%Low
Short Interest?87.3K
Days to Cover?1.0
Free Float4.9M
Avg Daily Volume726.4K
Settlement Date2026-10-15
Financial Health
Current Ratio?7.01Strong
Quick Ratio?7.01Strong
Cash Ratio?4.13Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.33CHEAP▾
Peers100
S&P91
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-421.1%WEAK▾
S&P3
ROA?-248.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-61926000
Enterprise Value?$12.5M
Fundamentals ratios updated end of day